Lexitas Pharma Services’ Post

Lexitas CEO Jeanne Hecht covers the state of clinical trial funding and provides specific advice for founders on how to structure the investor pitch. Having looked at many dozens of investor pitch decks, Jeanne has identified 5 areas where founders often fall short. Check out the great insights! _________________________ #ophthalmology #clinicaltrials #lifesciences

No matter the phase of your project, from pilot study to Phase IV post-market study, MERIT provides the expertise and technology to help you achieve your development goals. We seamlessly manage the imaging components of your trial, creating efficiencies for your #drugdevelopment. Check out summaries of two of our #ophthalmology case studies to learn more: https://lnkd.in/dPrVxdHZ #MERITCRO #YourClinicalEndpointExpert #clinicaltrials #clinicalresearch #casestudy #imagingsolutions

"Our team of pathology, scientific research, data, and project management experts is ready to help you overcome your toughest challenges. Get in touch, and let's schedule a meeting. I would be delighted to share our latest developments and service offerings with you." #ONCOLOGY #clinicalresearch #drugdevelopment #clinicaltrials #pathology #IHC #Flowcytometry #cytogenetics #FISH #digitalpathology #globallogistics #centrallabs

𝐖𝐞 𝐚𝐥𝐥 𝐥𝐨𝐯𝐞 𝐁𝐢𝐫𝐭𝐡𝐝𝐚𝐲𝐬, 𝐝𝐨𝐧’𝐭 𝐰𝐞?  But, have you ever wondered, when was the first clinical trial “born”? James Lind often receives credit for being the author of the first clinical trial in May 1747. However, the roots of clinical research stretch even further back in time⌛ Beginning with this intriguing question, we are excited to announce our new rubric – “𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐔𝐧𝐛𝐨𝐱𝐞𝐝”🎉 At MONIPOL, we believe the Clinical Research industry is very interesting: from impacting patient health to navigating regulatory frameworks, it's a field where every day brings new challenges and opportunities for growth. That's why we're committed to helping individuals learn more about these topics, raising awareness, and enhancing the overall understanding of the clinical research industry in the public eye. Follow us for more #insightful content 🚀  #ClinicalResearch #ClinicalTrials #CRO 

"Our team of pathology, scientific research, data, and project management experts is ready to help you overcome your toughest challenges. Get in touch, and let's schedule a meeting. I would be delighted to share our latest developments and service offerings with you." #ONCOLOGY #clinicalresearch #drugdevelopment #clinicaltrials #pathology #IHC #Flowcytometry #cytogenetics #FISH #digitalpathology #globallogistics #centrallabs

As the clinical trial process begins, life sciences teams face two tough questions: what does a feasible trial look like, and which site is the best option? 🤷♂️ With access to deep, far-ranging, and regularly-updated data sources like TA Scan, clinical trial teams can develop deeper insights and make better calls on trial feasibility, site selection, and diversity. ✔ Learn how in this blog post: https://buff.ly/4bVnEXq #ClinicalResearch #ClinicalTrials #PatientRecruitment #TrialFeasibility #SiteSelection #HealthEquity #DEI #DataScience #TAScan

Register for this webinar to learn how configurable solutions are transforming study launches by reducing coding errors, enhancing consistency across studies and enabling the acquisition of more reliable data. This not only streamlines the process but also makes it more cost-effective compared to traditional customized solutions that require complex and lengthy implementations.

Surge's €7.5M Funding Round: A Boon for Telemedicine & African Healthcare   The successful €7.5 million fundraising by SurgeCare, a European company pioneering immune system decryption for precision medicine, caught my attention. While Surge itself isn't African, its focus on personalized healthcare solutions resonates deeply with Africa's evolving telemedicine and telehealth space.   Here's why this is exciting news: Precision medicine holds immense potential: Tailoring treatments based on individual needs can significantly improve healthcare outcomes, where access to specialized care is limited. Surge's advancements can inspire VC trends: This significant investment by Eurazeo and other partners could encourage more VC interest in telemedicine solutions across Africa, leading to increased innovation and funding. SurgeLab™M and PreCyte® offer promising applications: These innovations focused on acquiring individualized immune signatures and predicting post-operative complications align perfectly with the need for remote diagnostics and personalized care in telemedicine. A bright future for African health: Surge's success story is a testament to the growing importance of personalized healthcare solutions. I'm optimistic that this will pave the way for more telemedicine advancements in Africa, ultimately improving the health and well-being of the continent's population.   Kudos to the SurgeCare team! Their dedication to precision medicine inspires us all. #telemedicine #africa #healthcare #precisionmedicine #venturecapital

ASCP Poster Presentation Announcement! 📣 Join Elan Cohen, Principal Investigator at CenExel HRI, on May 29 from 11:15-1pm ET in Salon 4 for a poster presentation discussing the ever important topic of, "Exploring Non-US Rater Work Stress and Burnout: How Can We Do Better to Preserve Our Primary Endpoint Evaluators?" For more information on how #CenExel can support your clinical trials, please visit www.CenExel.com! #ASCP2024 #PosterPresentation #ClinicalResearch

We just had an insightful conversation with Doug Drysdale, CEO of Cybin Inc, about the significant strides Cybin is making in psychedelic medicine. Here's what we uncovered about Cybin's journey and the road ahead for 2024: - Highlighting Cybin Inc's financial achievement with an oversubscribed private placement of $150 million, orchestrated by leading investors such as Deep Track Capital and RA Capital Management. - Celebrating the FDA’s Breakthrough Therapy Designation for CYB003, which underscores its potential in revolutionizing the treatment of Major Depressive Disorder, backed by compelling four-month durability data. - Outlining the strategic approach for the upcoming Phase 3 trial in mid-2024. Don’t miss this deep dive into the promising future of psychedelic medicine with Cybin! #psychedelictherapy #psychedelicresearch #psychedelicscience